Injury guide

Cancer Behind the Nose: Care and Claim Questions

A doctor must diagnose cancer behind the nose. Keep care and device records, and ask what a claim needs without assuming the device caused it.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202612 sources

This may apply to you if

  • Identify the actual Philips model and your dates of use.
  • Bring the diagnosis and treatment records for an individual legal check.
  • Tell the lawyer about any replacement, earlier registration or agreement.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Grégoire Justeau · Department of Respiratory and Sleep Medicine, Angers University Hospital, France · First-listed author of the original CPAP cancer cohort

Finding: The 4,447-person cohort found no increased overall cancer incidence among Philips users compared with other brands. Its observational design and follow-up cannot exclude every risk or decide an individual cause.

Justeau original CPAP cancer cohort, 2022 (opens in a new tab) · Jul 14, 2022 · Checked Oct 3, 2026

Joy Flowers Conti · United States District Court for the Western District of Pennsylvania · Senior United States District Judge

Finding: The January 16, 2026 opinion grants remand of the Graham case to Kentucky state court. It records past settlements and a January 31, 2025 private injury-settlement registration date; it does not decide personal medical cause or injury compensation.

Graham court opinion, January 16, 2026 (opens in a new tab) · Jan 16, 2026 · Checked Oct 3, 2026

The evidence and its limits

Pays de la Loire Sleep Cohort Study Group; Angers University Hospital, France · European Respiratory Journal · 2022

Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea

Design:
Cohort
Participants:
4,447 patients, including 1,648 Philips and 2,799 other-device users
Finding:
No association with increased overall cancer incidence was found over a median 7.2-year follow-up.
Main limitation
Observational design, possible unmeasured factors and limited ability to detect certain cancers. Two authors disclosed Philips lecture honoraria outside the study. This does not establish individual cause or all-model safety.

Read the source: Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea (opens in a new tab) · Checked Oct 3, 2026

Food and Drug Administration · 2024

FDA review of Philips foam testing; not a patient outcome study

Design:
Agency review
Participants:
Not applicable: review of device testing, not a patient cohort
Finding:
The April 2024 summary reports that FDA found shared testing insufficient to fully evaluate risks in October 2023 and requested additional testing.
Main limitation
Potential-risk review and dated testing assessment, not proof of any person’s cancer cause or a new 2026 testing result.

Read the source: FDA review of Philips foam testing; not a patient outcome study (opens in a new tab) · Checked Oct 3, 2026

The short answer

What is nasopharyngeal cancer?
It is cancer in tissue behind the nose, in the upper throat. The diagnosis needs a doctor’s assessment. [12]
What signs should I see a doctor about?
A neck lump, hearing changes or nosebleeds need a check. They can have causes other than this cancer. [12]
How is it diagnosed and treated?
Doctors may use an exam, a scope, scans and tissue tests. The care plan depends on the cancer, your health and preferences. [12]
What does research say about device and cancer risk?
The study compared Philips users with users of other brands. It found no higher overall cancer rate for Philips users. It cannot rule on every risk. It cannot say what caused one person’s cancer. [8]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

When it fits this case

  • Identify the actual Philips model and your dates of use.
  • Bring the diagnosis and treatment records for an individual legal check.
  • Tell the lawyer about any replacement, earlier registration or agreement.

What is nasopharyngeal cancer?

It is cancer in tissue behind the nose, in the upper throat. The diagnosis needs a doctor’s assessment.

NCI calls this area the nasopharynx. Its patient guide describes a head-and-neck cancer, not a finding that CPAP caused the disease. Ask for the exact diagnosis and site in writing. Keep device notes separate so a general recall does not replace the clinical explanation of what was found.

What signs should I see a doctor about?

A neck lump, hearing changes or nosebleeds need a check. They can have causes other than this cancer.

NCI also describes ear pain, a sore throat and a stuffy nose among possible signs. Tell the clinician when symptoms began and about device use. Do not diagnose cancer from a recall notice or wait for a legal decision before asking about the symptoms.

How is it diagnosed and treated?

Doctors may use an exam, a scope, scans and tissue tests. The care plan depends on the cancer, your health and preferences.

A biopsy removes cells or tissue for cancer checks under a microscope. NCI describes care options such as radiation and drugs, with plans led by a team familiar with this cancer. Ask what the findings mean and what alternatives fit; this page does not choose a regimen or predict a cure.

What does research say about device and cancer risk?

The study compared Philips and other device users. It found no higher overall cancer rate for Philips users. It cannot decide every risk or one person’s cause.

The study followed 4,447 patients, with 1,648 Philips users and 2,799 other-device users. It was not a trial that assigned devices. Its design and follow-up may miss certain risks; two authors disclosed Philips lecture fees outside the study. FDA’s separate foam guidance still describes potential risks rather than diagnosing your cancer.

Who may have a claim to check?

Ask a lawyer to check the diagnosis, actual device and law. A diagnosis alone does not mean a firm or program will take the claim.

A civil case reviews harm and responsibility. Ask which product records and dates matter and disclose any earlier claim or release. The court’s historical private injury-program discussion is not a universal rule for every cancer patient; get the actual agreement if that program is part of the review.

What records and care steps should I keep?

Keep health, model and serial records. Talk to the provider before changing device use or treatment.

FDA says some patients face more risk from stopping a recalled device than continuing it. For CPAP or BiPAP, do not add a filter, remove foam or use ozone or UV cleaners. Ask about covered health-record copies and written legal fees and expenses, without treating record gathering as representation.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. HHS: Your Medical RecordsHHS: Your Medical Records · regulator
  2. Federal courts: civil casesFederal courts: civil cases · court
  3. ABA: fees paid from a successful claimABA: fees paid from a successful claim
  4. SDNY: filing time limitsSDNY: filing time limits · court
  5. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  6. FDA recalled Philips device patient guidanceFDA recalled Philips device patient guidance · regulator
  7. FDA foam testing summaryFDA foam testing summary · regulator
  8. Justeau original CPAP cancer cohort, 2022Justeau original CPAP cancer cohort, 2022 · study
  9. Graham court opinion, January 16, 2026Graham court opinion, January 16, 2026 · court
  10. Philips announced (Apr 29, 2024) a $1.1 billion total resolution of US Respironics personal-injury and medical-monitoring litigation; the official court settlement site confirms $1.075 billion for personal-injury claims in MDL 3014 and Massachusetts state court (~58,000 registrants; injuries diagnosed by Apr 29, 2024 qualify). A January 16, 2026 court opinion says payments were anticipated in early 2026; no admission of liability.respironicspisettlement.com · Apr 29, 2024
  11. Philips announced resolution of the US economic-loss class litigation in MDL 3014 (Sept 7, 2023 press release): predefined cash awards by device type, extended warranties, and a return bonus; Philips' release cites a EUR 575 million Q1 2023 provision and explicitly excludes personal injury and medical monitoring claims. The commonly cited $479 million settlement figure is from secondary press coverage (Drugwatch), not Philips' own release — flagged accordingly.usa.philips.com · Sep 7, 2023
  12. NCI PDQ patient nasopharyngeal cancer, updated May12,2025

Checked against 10 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026